An Open-Label, Crossover Trial of Mirtazapine (15 and 30 mg) in Cancer Patients with Pain and Other Distressing Symptoms

Authors: Theobald D.E.1; Kirsh K.L.; Holtsclaw E.; Donaghy K.; Passik S.D.

Source: Journal of Pain and Symptom Management, Volume 23, Number 5, May 2002 , pp. 442-447(6)

Publisher: Elsevier

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: Mirtazapine; advanced cancer; pain; depression; symptoms; quality of life

Language: English

Document Type: Short communication

DOI: 10.1016/S0885-3924(02)00381-0

Affiliations: 1: Oncology Symptom Control & Research, Community Cancer Care, , Indianapolis, IN, USA

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A